Castlight Health, inc. (NYSE:CSLT) insider Giovanni M. Colella sold 23,800 shares of the firm’s stock in a transaction that occurred on Tuesday, August 15th. The shares were sold at an average price of $4.05, for a total value of $96,390.00. Following the completion of the transaction, the insider now directly owns 78,906 shares of the company’s stock, valued at $319,569.30. The transaction was disclosed in a document filed with the SEC, which is available through this link.

Castlight Health, inc. (NYSE:CSLT) traded down 3.70% during midday trading on Wednesday, hitting $3.90. The stock had a trading volume of 315,148 shares. The stock’s market cap is $513.58 million. Castlight Health, inc. has a one year low of $3.05 and a one year high of $5.50. The firm has a 50 day moving average price of $4.25 and a 200 day moving average price of $3.80.

Castlight Health, inc. (NYSE:CSLT) last announced its earnings results on Wednesday, August 2nd. The software maker reported ($0.07) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.09) by $0.02. Castlight Health, inc. had a negative net margin of 42.54% and a negative return on equity of 36.30%. The company had revenue of $32.10 million for the quarter, compared to the consensus estimate of $31.14 million. During the same period in the previous year, the business earned ($0.11) EPS. The company’s revenue was up 36.0% on a year-over-year basis. Equities analysts expect that Castlight Health, inc. will post ($0.25) EPS for the current year.

TRADEMARK VIOLATION NOTICE: This story was posted by American Banking News and is the sole property of of American Banking News. If you are accessing this story on another publication, it was copied illegally and republished in violation of U.S. & international trademark & copyright legislation. The legal version of this story can be accessed at https://www.americanbankingnews.com/2017/08/16/castlight-health-inc-cslt-insider-sells-96390-00-in-stock.html.

A number of hedge funds have recently made changes to their positions in the stock. Stifel Financial Corp increased its stake in shares of Castlight Health, inc. by 4.3% in the first quarter. Stifel Financial Corp now owns 36,500 shares of the software maker’s stock valued at $133,000 after buying an additional 1,500 shares during the period. Oxford Asset Management purchased a new stake in shares of Castlight Health, inc. during the first quarter valued at about $102,000. Teachers Advisors LLC increased its stake in shares of Castlight Health, inc. by 8.1% in the fourth quarter. Teachers Advisors LLC now owns 62,781 shares of the software maker’s stock valued at $311,000 after buying an additional 4,717 shares during the period. FNY Partners Fund LP purchased a new stake in shares of Castlight Health, inc. during the first quarter valued at about $164,000. Finally, State Street Corp increased its stake in shares of Castlight Health, inc. by 11.3% in the fourth quarter. State Street Corp now owns 663,065 shares of the software maker’s stock valued at $3,277,000 after buying an additional 67,459 shares during the period. 40.17% of the stock is currently owned by institutional investors.

A number of equities research analysts have commented on the company. ValuEngine cut Castlight Health, inc. from a “hold” rating to a “sell” rating in a report on Thursday, August 10th. Cowen and Company reiterated a “market perform” rating and set a $4.50 target price (up previously from $4.00) on shares of Castlight Health, inc. in a report on Thursday, August 3rd. BidaskClub cut Castlight Health, inc. from a “hold” rating to a “sell” rating in a report on Sunday, July 30th. Zacks Investment Research upgraded Castlight Health, inc. from a “sell” rating to a “hold” rating in a report on Tuesday, June 27th. Finally, Chardan Capital assumed coverage on Castlight Health, inc. in a report on Tuesday, June 6th. They set a “buy” rating and a $4.50 target price on the stock. Three equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and two have given a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus target price of $4.57.

About Castlight Health, inc.

Castlight Health, Inc offers a health benefits platform that engages employees to make healthcare decisions, and enables employers to communicate and measure their benefit programs. The Company operates through cloud-based products segment. Its technology offering aggregates data and applies analytics to make healthcare data transparent.

Insider Buying and Selling by Quarter for Castlight Health, inc. (NYSE:CSLT)

Receive News & Ratings for Castlight Health inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health inc. and related companies with MarketBeat.com's FREE daily email newsletter.